Karsten Kretschmer

Prof. Karsten Kretschmer is a Professor of Molecular and Cellular Immunology/Focus Immune Regulation at the Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden since 2013. His academic career demonstrates a strong progression from PhD studies at the Helmholtz Center for Infection Research to postdoctoral work at Harvard Medical School, establishing him as a leading researcher in immunology.

His research focuses on molecular and cellular pathways governing Foxp3+ regulatory T (Treg) cells, which are critical for maintaining immune homeostasis and preventing autoimmunity.

• Investigates cell signaling and epigenetics in Treg cell biology
• Studies transcription regulation in tolerance and autoimmunity (including miRNAs)
• Examines mechanisms of suppression by Treg cells
• Develops approaches to enhance Treg cell activity for immune tolerance

Analysis of Prof. Kretschmer's publications reveals a consistent focus on regulatory T cell biology across two decades, with particular emphasis on Foxp3 expression, Treg cell development, and potential therapeutic applications for autoimmune diseases. His work bridges basic immunological research with clinical applications.

His scientific achievements have been recognized through several prestigious awards:

• EYEnovative Research Award (2013)
• Election to the Henry Kunkel Society (since 2012)
• Heinrich-Büssing Award (2004)
• DFG Postdoctoral Fellowship (2003-2004)

Prof. Kretschmer maintains active collaborations through his membership in the Paul-Langerhans Institute Dresden (since 2009) and leads the Kretschmer Group at CRTD, where his team utilizes advanced methodologies including mouse models of autoimmune diseases, molecular genetic tools, and flow cytometry to investigate T cell biology. His work has significant potential for developing novel cell-based therapies for autoimmune conditions and transplantation medicine.